Module 3: Secondary Prevention

Secondary prevention strategies for patients with established ASCVD.

Risk Calculator Primary Prevention Secondary Prevention Severe Hyperchol.Hypertriglyceridemia Diabetes Special Populations Lp(a) & ApoB Monitoring

Secondary Prevention: ASCVD Risk Assessment

For patients WITH established atherosclerotic cardiovascular disease. Complete the form below to determine risk stratification and guideline-directed therapy.

ASCVD Event History

Select all prior major ASCVD events

Prior myocardial infarction (MI)?

Prior ischemic stroke?

Symptomatic PAD?

Multiple ASCVD events?

Current Lipid-Lowering Therapy

Enter current LDL-C level and medications

Current LDL-C*

mg/dL

Current statin intensity

On ezetimibe?

On PCSK9 inhibitor?

Statin intolerant?

Additional High-Risk Conditions

Check all conditions that apply. These influence risk stratification (high vs very high).

Age >= 65 yearsHeterozygous familial hypercholesterolemia (FH)Diabetes mellitusHypertension (on antihypertensive therapy)Chronic kidney disease (eGFR < 60 mL/min/1.73 m²)Current smokingPrior CABG or PCI (coronary revascularization)History of heart failure

This tool is intended for use by healthcare professionals and does not replace clinical judgment. Always refer to the full 2026 ACC/AHA Guideline on the Management of Dyslipidemia for complete recommendations.